Cite
HARVARD Citation
Lutz, J. et al. (2017). Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. Npj vaccines. pp. 1-9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lutz, J. et al. (2017). Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines. Npj vaccines. pp. 1-9. [Online].